Self-emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-cancer genistein: Development, appraisal and ex-vivo intestinal permeation

International Journal of Pharmaceutics

Volumn 511, Issue 2, 2016, Pages 745-756

  Shehata, Eman M M ^a   Elnaggar, Yosra S R ^a,b   Galal, Saly ^a   Abdallah, Ossama Y ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Pharos University of Alexandria   (Egypt)

Author keywords

Genistein; Intestinal permeation; Phospholipid; Self emulsifying

Indexed keywords

CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; GENISTEIN; LABRASOL; NANOCARRIER; POLYSORBATE 80; SELF EMULSIFYING PHOSPHOLIPID PRECONCENTRATE; UNCLASSIFIED DRUG; DRUG CARRIER; EMULSION; NANOPARTICLE; PHOSPHOLIPID; SURFACTANT;

ANIMAL EXPERIMENT; ARTICLE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DRUG STABILITY; EMULSION; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; SOLUBILITY; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; DRUG CARRIERS; DRUG LIBERATION; DRUG STABILITY; EMULSIONS; GENISTEIN; INTESTINAL ABSORPTION; MALE; NANOPARTICLES; PARTICLE SIZE; PHOSPHOLIPIDS; RATS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 84980329108     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.07.078     Document Type: Article

References (51)

1. Allam, A.N., Komeil, I.A., Fouda, M.A., Abdallah, O.Y., Preparation, characterization and in vivo evaluation of curcumin self-nano phospholipid dispersion as an approach to enhance oral bioavailability. Int. J. Pharm. 489 (2015), 117–123, 10.1016/j.ijpharm.2015.04.067.
2. Andlauer, W., Fürst, P., Absorption and metabolism of phenolic phytopharmaceuticals in the isolated rat small intestine with special reference to isoflavones and anthocyanins—a review. Pol. J. Food Nutr. Sci. 12:53 (2003), 117–127.
3. Andlauer, W., Kolb, J., Stehle, P., Fu, P., Absorption and metabolism of genistein in isolated rat small intestine. J. Nutr. 130 (2000), 843–846.
4. Aungst, B.J., Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000), 429–442, 10.1002/(SICI)1520-6017(200004)89:4<429:AID-JPS1>3.0.CO;2-J.
5. Baek, M.K., Lee, J.H., Cho, Y.H., Kim, H.H., Lee, G.W., Self-microemulsifying drug-delivery system for improved oral bioavailability of pranlukast hemihydrate: preparation and evaluation. Int. J. Nanomed. 8 (2013), 167–176, 10.2147/IJN.S37338.
6. Chavda, H., Patel, J., Chavada, G., Dave, S., Patel, A., Patel, C., Self-nanoemulsifying powder of isotretinoin: preparation and characterization. J. Powder Technol. 2013 (2013), 1–9, 10.1155/2013/108569.
7. Chen, J., Wang, S., Jia, X., Bajimaya, S., Lin, H., Tam, V.H., Al, C.E.T., Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab. Dispos. 33 (2005), 1777–1784, 10.1124/dmd.105.003673.are.
8. Crupi, V., Ficarra, R., Guardo, M., Majolino, D., Stancanelli, R., Venuti, V., UV–vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins. J. Pharm. Biomed. Anal. 44 (2007), 110–117, 10.1016/j.jpba.2007.01.054.
9. Deokate, U.A., Shinde, N., Bhingare, U., Novel approaches for development and characterization of SMEDDS: review. Int. J. Curr. Pharm. Res. 5 (2013), 5–12.
10. El-Refaie, W.M., Elnaggar, Y.S.R., El-Massik, M.A., Abdallah, O.Y., Novel self-assembled, gel-core hyaluosomes for non-invasive management of osteoarthritis: in-vitro optimization, ex-vivo and in-vivo permeation. Pharm. Res. 32 (2015), 2901–2911, 10.1007/s11095-015-1672-8.
11. Elnaggar, Y.S.R., El-Massik, M.A., Abdallah, O.Y., Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int. J. Pharm. 380 (2009), 133–141, 10.1016/j.ijpharm.2009.07.015.
12. Elsheikh, M.A., Elnaggar, Y.S.R., Gohar, E.Y., Abdallah, O.Y., Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int. J. Nanomed. 7 (2012), 3787–3802, 10.2147/IJN.S33186.
13. Freag, M.S., Elnaggar, Y.S.R., Abdallah, O.Y., Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int. J. Nanomed. 8 (2013), 2385–2397, 10.2147/IJN.S45231.
14. Freag, M.S., Elnaggar, Y.S.R., Abdallah, O.Y., Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Int. J. Pharm. 454 (2013), 462–471, 10.1016/j.ijpharm.2013.06.039.
15. Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., Setzer, C., Quinkert, R.O., Martin, F., Müller-Goymann, C., Phospholipids and lipid-based formulations in oral drug delivery. Pharm. Res. 27 (2010), 1469–1486, 10.1007/s11095-010-0130-x.
16. Ge, Z., Zhang, X.X., Gan, L., Gan, Y., Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability. Acta Pharmacol. Sin. 29 (2008), 990–997, 10.1111/j.1745-7254.2008.00825.x.
17. Gupta, S., Chavhan, S., Sawant, K.K., Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf. A: Physicochem. Eng. Asp. 392 (2011), 145–155, 10.1016/j.colsurfa.2011.09.048.
18. Gupta, S., Kesarla, R., Omri, A., Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm., 2013, 2013, 10.1155/2013/848043.
19. Gursoy, R.N., Benita, S., Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004), 173–182, 10.1016/j.biopha.2004.02.001.
20. Hamid, K.A., Katsumi, H., Sakane, T., Yamamoto, A., The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats. Int. J. Pharm. 379 (2009), 100–108, 10.1016/j.ijpharm.2009.06.018.
21. Hanke, U., May, K., Rozehnal, V., Nagel, S., Siegmund, W., Weitschies, W., Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2). Eur. J. Pharm. Biopharm. 76 (2010), 260–268, 10.1016/j.ejpb.2010.06.008.
22. Islam, M.A., Bekele, R., vanden Berg, J.H.J., Kuswanti, Y., Thapa, O., Soltani, S., van Leeuwen, F.X.R., Rietjens, I.M.C.M., Murk, A.J., Deconjugation of soy isoflavone glucuronides needed for estrogenic activity. Toxicol. In Vitro 29 (2015), 706–715, 10.1016/j.tiv.2015.01.013.
23. Kang, B.K., Lee, J.S., Chon, S.K., Jeong, S.Y., Yuk, S.H., Khang, G., Lee, H.B., Cho, S.H., Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274 (2004), 65–73, 10.1016/j.ijpharm.2003.12.028.
24. Kim, A.R., Lim, S.J., Lee, B.J., Metabolic inhibition and kinetics of raloxifene by pharmaceutical excipients in human liver microsomes. Int. J. Pharm. 368 (2009), 37–44, 10.1016/j.ijpharm.2008.09.049.
25. Kwon, S.H., Kim, S.Y., Ha, K.W., Kang, M.J., Huh, J.S., Im, T.J., Kim, Y.M., Park, Y.M., Kang, K.H., Lee, S., Chang, J.Y., Lee, J., Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch. Pharm. Res. 30 (2007), 1138–1143.
26. Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., Deng, Y., A review on phospholipids and their main applications in drug delivery systems. Asian J. Pharm. Sci., 2014, 1–18, 10.1016/j.ajps.2014.09.004.
27. Miyamoto, M., Hirano, K., Ichikawa, H., Fukumori, Y., Akine, Y., Tokuuye, K., Preparation of gadolinium-containing emulsions stabilized with phosphatidylcholine-surfactant mixtures for neutron-capture therapy. Chem. Pharm. Bull. 47 (1999), 203–208, 10.1248/cpb.47.203.
28. Motlekar, N., Khan, M.A., Youan, B.-B.C., Preparation and characterization of genistein containing poly(ethylene glycol) microparticles. J. Appl. Polym. Sci. 101 (2006), 2070–2078, 10.1002/app.23827.
29. Nipun, T.S., Ashraful Islam, S.M., SEDDS of gliclazide: preparation and characterization by in-vitro, ex-vivo and in-vivo techniques. Saudi Pharm. J. 22 (2013), 343–348, 10.1016/j.jsps.2013.06.001.
30. Oberle, R.L., Moore, T.J., Krummel, D.A.P., Evaluation of mucosal damage of surfactants in rat jejunum and colon. J. Pharmacol. Toxicol. Methods 33 (1995), 75–81, 10.1016/1056-8719(94)00060-H.
31. Pouton, C.W., Porter, C.J., Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60 (2008), 625–637, 10.1016/j.addr.2007.10.010.
32. Ro, J., Kim, H., Shim, B.H., Kim, I., Kim, J.T., Kim, H., Cho, J.M., Khadka, P., Yun, G., Park, K., Park, Y.J., Lee, K., Han, J., Lee, J., In vitro metabolic modulation of aryl sulfotransferases by pharmaceutical excipients. Bull. Korean Chem. Soc. 35 (2014), 2577–2580.
33. Ruan, L.P., Chen, S., Yu, B.Y., Zhu, D.N., Cordell, G.A., Qiu, S.X., Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur. J. Med. Chem. 41 (2006), 605–610, 10.1016/j.ejmech.2006.01.013.
34. Shahba, A.A., Mohsin, K., Alanazi, F.K., The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations. AAPS PharmSciTech 13 (2012), 522–533, 10.1208/s12249-012-9773-8.
35. Shanmugam, S., Park, J.H., Kim, K.S., Piao, Z.Z., Yong, C.S., Choi, H.G., Woo, J.S., Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS). Int. J. Pharm. 412 (2011), 99–105, 10.1016/j.ijpharm.2011.04.015.
36. Maheshwari, M., Comparative bioavailability of curcumin, turmeric and BiocurcumaxTM in traditional vehicles using non-everted rat intestinal sac model. J. Funct. Foods 2 (2010), 60–65, 10.1016/j.jff.2010.01.004.
37. Si, H.Y., Li, D.P., Wang, T.M., Zhang, H.L., Ren, F.Y., Xu, Z.G., Zhao, Y.Y., Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. J. Nanosci. Nanotechnol. 10 (2010), 2325–2331.
38. Silva, A.P.C., Nunes, B.R., De Oliveira, M.C., Koester, L.S., Mayorga, P., Bassani, V.L., Teixeira, H.F., Development of topical nanoemulsions containing the isoflavone genistein. Pharmazie 64 (2009), 32–35.
39. Singh, B., Khurana, L., Bandyopadhyay, S., Kapil, R., Katare, O.O., Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv. 18 (2011), 599–612, 10.3109/10717544.2011.604686.
40. Song, W.H., Yeom, D.W., Lee, D.H., Lee, K.M., Yoo, H.J., Chae, B.R., Song, S.H., Choi, Y.W., In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system. Arch. Pharm. Res. 37 (2014), 626–635, 10.1007/s12272-013-0202-7.
41. Stokes, A.H., Kemp, D.C., Faiola, B., Jordan, H.L., Merrill, C.L., Hailey, J.R., Brown, R.E., Bailey, D.W., Effects of Solutol (Kolliphor) and cremophor in polyethylene glycol 400 vehicle formulations in Sprague-Dawley rats and Beagle dogs. Int. J. Toxicol. 32 (2013), 189–197, 10.1177/1091581813485452.
42. Swenson, E.S., Milisen, W.B., Curatolo, W., Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm. Res. 11 (1994), 1132–1142.
43. Tang, J., Xu, N., Ji, H., Liu, H., Wang, Z., Wu, L., Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment. Int. J. Nanomed. 6 (2011), 2429–2435, 10.2147/ijn.s24185.
44. Tiwari, S.B., Amiji, M.M., Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J. Nanosci. Nanotechnol. 6 (2006), 3215–3221.
45. Venkatesh, G., Majid, M.I.a, Mansor, S.M., Nair, N.K., Croft, S.L., Navaratnam, V., In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev. Ind. Pharm. 36 (2010), 735–745, 10.3109/03639040903460446.
46. Vitale, D.C., Piazza, C., Melilli, B., Drago, F., Salomone, S., Isoflavones: estrogenic activity, biological effect and bioavailability. Eur. J. Drug Metab. Pharmacokinet. 38 (2013), 15–25, 10.1007/s13318-012-0112-y.
47. Wu, W., Wang, Y., Que, L., Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 63 (2006), 288–294, 10.1016/j.ejpb.2005.12.005.
48. Yang, Z., Kulkarni, K., Zhu, W., Hu, M., Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med. Chem. 12 (2012), 1264–1280, 10.1016/j.biotechadv.2011.08.021.Secreted.
49. Yoo, J.H., Shanmugam, S., Thapa, P., Lee, E., Balakrishnan, P., Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch. Pharm. Res. 33 (2010), 417–426, 10.1007/s12272-010-0311-5.
50. Zhou, J., Zhou, M., Yang, F.-F., Liu, C.-Y., Pan, R.-L., Chang, Q., Liu, X.-M., Liao, Y.-H., Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. Mol. Pharm. 12 (2015), 1084–1095, 10.1021/mp5005838.
51. Zhu, S., Hong, M., Liu, C., Pei, Y., Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm. Dev. Technol. 14 (2009), 642–649, 10.3109/10837450902882385.